ClinicalTrials.gg
Sign In

Sexually Transmitted Diseases, Viral clinical trials

The registry lists 24 studies for Sexually Transmitted Diseases, Viral across more than 10 countries. 1 are recruiting or about to start. 2 of them are mainly about Sexually Transmitted Diseases, Viral (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-02. Counting its 13 narrower conditions too, such as HIV Infections: 7,678 studies, 708 open.

Get an email when these change. Save the Sexually Transmitted Diseases, Viral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
13
Terminated
4
Active, not recruiting
3
Status unknown
3
Recruiting
1

Phase

Phase 1
6
Phase 2
5
Phase 4
2
Phase 3
1

Where

United States
12
South Africa
1
Dominican Republic
1
Argentina
1
Denmark
1
Malawi
1

Who runs them

Columbia University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · University of North Carolina, Chapel Hill (1) · Myrexis Inc. (1) · Verrica Pharmaceuticals Inc. (1) · University of Buenos Aires (1) · National Development and Research Institutes, Inc. (1) · Rosa Jimenez (1)

What is being tested here

Drugs under test in Sexually Transmitted Diseases, Viral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Emtricitabine002
Tenofovir012
BG505001
Ad26.Mos4.HIV001
PGT-121001
PGDM1400001
VRC07-523LS001
Darunavir001
Cobicistat001
Tenofovir alafenamide001

Drug classes tested here Reverse transcriptase inhibitors 3

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 1 Sexually Transmitted Diseases, Viral studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 1 (100%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.

Recruiting studies that take each age, of 1
AgeWomenMen
100 (0%)0 (0%)
180 (0%)0 (0%)
301 (100%)0 (0%)
401 (100%)0 (0%)
501 (100%)0 (0%)
651 (100%)0 (0%)
751 (100%)0 (0%)
851 (100%)0 (0%)

Across all 24 studies, recruiting or not: 50% stop at 75 or younger and 38% at 65; 17% take children; 17% are for women only and 13% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 24 of 24. search them.